G1 Therapeutics Inc
(GTHX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 16,546 | 14,476 | 14,873 | 12,300 | 42,392 |
| Cost of Goods | 733 | 1,079 | 1,256 | 3,076 | 1,404 |
| Gross Profit | 15,813 | 13,397 | 13,617 | 9,224 | 40,988 |
| Operating Expenses | 20,081 | 22,524 | 22,802 | 25,668 | 29,876 |
| Operating Income | -3,535 | -9,048 | -8,929 | -16,368 | 11,516 |
| Interest Expense | 2,726 | 1,978 | 2,124 | 2,115 | 2,710 |
| Other Income | 792 | 807 | 1,077 | 1,184 | 1,212 |
| Pre-tax Income | -5,469 | -10,219 | -9,976 | -17,299 | 10,018 |
| Income Tax | N/A | N/A | 902 | 905 | 1,308 |
| Net Income Continuous | -5,469 | -10,219 | -10,878 | -18,204 | 8,710 |
| Net Income | $-5,469 | $-10,219 | $-10,878 | $-18,204 | $8,710 |
| EPS Basic Total Ops | -0.10 | -0.20 | -0.22 | -0.35 | 0.17 |
| EPS Basic Continuous Ops | -0.10 | -0.20 | -0.21 | -0.35 | 0.17 |
| EPS Diluted Total Ops | -0.10 | -0.20 | -0.19 | -0.35 | 0.14 |
| EPS Diluted Continuous Ops | -0.10 | -0.20 | -0.18 | -0.35 | 0.14 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.20 | -0.21 | -0.35 | 0.14 |
| EBITDA(a) | $-3,576 | $-8,638 | $-8,489 | $-15,438 | $11,459 |